If you've tried multiple antidepressants, been to therapy, and still feel trapped by depression, it's natural to feel hopeless. But here's the truth: up to 30% of depression cases are treatment-resistant—and that resistance is not the end of the road. It's a signal that different, more advanced treatments are needed.
Why Standard Treatments Sometimes Fail
Traditional antidepressants target the monoamine system (serotonin, norepinephrine). But depression is complex, involving glutamate pathways, neuroinflammation, and disrupted brain circuitry. When monoamine-targeting meds fail, treatments that address these other mechanisms can succeed.
Advanced Options That Work When Meds Don't
- TMS Therapy: Non-invasive magnetic stimulation of underactive brain regions. 60–70% response rate. Learn more.
- SPRAVATO® (esketamine): FDA-approved nasal spray targeting glutamate. Insurance-covered. See efficacy.
- IV Ketamine: Rapid-acting infusion, relief within hours. Explore.
- SAINT® Accelerated TMS: 5-day fMRI-guided protocol, up to 79–90% remission. Discover SAINT®.
You Haven't Tried Everything Yet
If you've only tried oral medications and talk therapy, you haven't yet explored the interventional treatments that are changing lives. These aren't experimental—they're FDA-cleared, insurance-covered, and backed by rigorous clinical research. Relief is possible, and it may be closer than you think.
In crisis? If you're having thoughts of self-harm, call or text 988 (Suicide & Crisis Lifeline) immediately, or go to your nearest emergency room.